School of Pharmacy, Kinki University, Japan.
J Pharm Biomed Anal. 2011 Jun 25;55(4):702-27. doi: 10.1016/j.jpba.2011.02.003. Epub 2011 Mar 5.
Glycans are widely distributed in biological systems in free state as well as conjugated forms as parts of glycoproteins, glycolipids, and proteoglycans. Because glycans are not synthesized directly by the corresponding genes but a combination of the related enzymes and substrates, the structures of glycans are quite diverse and sensitive with the changes of physiological conditions. Due to the extremely complex heterogeneities of glycans, it has been a big challenging target to analyze comprehensive glycan profiles (i.e. glycome) and determine characteristic glycan(s) for clinical use. Recent advances in separation sciences such as capillary/microchip electrophoresis and mass spectrometry have made it possible to analyze glycans for various practical uses. New emerging technologies of microarray and bioinformatics have also been applied to glycome/glycomics studies. In this review, recent topics on glycan analysis in clinical use are described with their historical background. Some results obtained by our studies are also shown.
糖链广泛分布于生物体系中,以游离态或与糖蛋白、糖脂和糖胺聚糖等结合的形式存在。由于糖链并非由相应的基因直接合成,而是相关酶和底物的组合,因此其结构具有多样性且对生理条件的变化较为敏感。由于糖链具有极其复杂的异质性,因此全面分析糖链图谱(即糖组学)并确定具有临床应用价值的特征性糖链一直是一个巨大的挑战。近年来,分离科学(如毛细管/微流控芯片电泳和质谱)的发展使得分析各种实际应用中的糖链成为可能。微阵列和生物信息学等新兴技术也已应用于糖组学/糖组学研究。本文将介绍临床应用中糖链分析的最新研究进展,并阐述其历史背景。同时还展示了我们研究团队的部分成果。